Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: Therapeutic effects and mechanisms of action

Journal of the Neurological Sciences

Volumn 160, Issue SUPPL. 1, 1998, Pages

  Haase, G ^a   Pettmann, B ^b   Vigne, E ^c   Castelnau Ptakhine, L ^a   Schmalbruch, H ^d   Kahn, A ^a  

^a INSTITUT COCHIN   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adenovirus vector; Amyotrophic lateral sclerosis; Gene therapy; Motor neuron diseases; Neurotrophic factors; Neurotrophin 3

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; NEUROTROPHIN 3; SOMATOMEDIN C; VIRUS VECTOR;

AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; DRUG EFFECT; GENE THERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; MOTONEURON; MOTOR NEURON DISEASE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; AXONAL TRANSPORT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMYOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; MICE; MICE, NEUROLOGIC MUTANTS; MOTOR NEURON DISEASE; MUSCLE, SKELETAL; NERVE GROWTH FACTORS; NEUROTROPHIN 3;

EID: 0031723577     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00207-X     Document Type: Conference Paper

References (56)

1. Acsadi G, Jani A, Massie B, et al. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 1994;3:579-84.
2. Aebischer P, Schluep M, Deglon N, et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med 1996;2:696-9.
3. Akli S, Caillaud C, Vigne E, et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 1993;3:224-8.
4. Baumgartner BJ, Shine HD. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci 1997;17:6504-11.
5. Braun S, Croizat B, Lagrange MC, Warter JM, Poindron P. Neurotrophins increase motoneurons' ability to innervate skeletal muscle fibers in rat spinal cord-human muscle cocultures. J Neurol Sci 1996;136:17-23.
6. Brunialti ALB, Poirier C, Schmalbruch H, Guenet JL. The mouse mutation progressive motor neuronopathy (pmn) maps to Chromosome 13. Genomics 1995;29:131-5.
7. Chiu AY, Zhai P, Dalcanto MC, et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 1995;6:349-62.
8. Coulpier M, Junier MP, Peschanski M, Dreyfus PA. Bcl-2 sensitivity differentiates two pathways for motoneuronal death in the wobbler mutant mouse. J Neurosci 1996;16:5897-904.
9. Depablo F, Delarosa EJ. The developing CNS: A scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci 1995;18:143-50.
10. Distefano PS, Curtis R. Receptor mediated retrograde axonal transport of neurotrophic factors is increased after peripheral nerve injury. In: Seil FJ, editor. Neural regeneration, vol. 103. Amsterdam, Elsevier Science, 1994:35-42.
11. Dittrich F, Ochs G, Grossewilde A, et al. Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons. Exp Neurol 1996;141:225-39.
12. Dittrich F, Thoenen H, Sendtner M. Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat. Ann Neurol 1994;35:151-63.
13. Eriksson NP, Lindsay RM, Aldskogius H. BDNF and NT-3 rescue sensory but not motoneurones following axotomy in the neonate. Neuroreport 1994;5:1445-8.
14. Ernfors P, Lee KF, Kucera J, Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994;77:503-12.
15. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994;369:658-61.
16. Finiels F, Ribotta MG, Barkats M, et al. Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases. Neuroreport 1995;6:2473-8.
17. Ghadge GD, Roos RP, Kang UJ, et al. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther 1995;2:132-7.
18. Gilgenkrantz H, Duboc D, Juillard V, et al. Transient gene expression after transfer into heart using first generation adenoviral vectors: role of the immune response. Hum Gene Ther 1995;10:1265-74.
19. Griesbeck O, Parsadanian AS, Sendtner M, Thoenen H. Expression of neurotrophins in skeletal muscle: Quantitative comparison and significance for motoneuron survival and maintenance of function. J Neurosci Res 1995;42:21-33.
20. Haase G, Kennel P, Pettmann B, et al. Gene therapy of a murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med 1997;3:429-36.
21. Henderson CE. Applications potentielles des neurotrophines dans les affections du motoneurone. In: Stratégie des thérapeutiques innovantes. Paris: Editions Frison-Roche, 1993:229-241.
22. Henderson CE. Neurotrophic factors as therapeutic agents in amyotrophic lateral sclerosis - Potential and pitfalls. In: Serratrice GT, Munsat TL, editors. Pathogenesis and therapy of amyotrophic lateral sclerosis, vol. 68. Philadelphia: Lippincott-Raven, 1995:235-40.
23. Henderson CE, Camu W, Mettling C, et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993;363:266-70.
24. Henderson CE, Phillips HS, Pollock RA, et al. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994;266:1062-4.
25. Hohn A, Leibrock J, Bailey K, Barde YA. Identification and characterization of a novel member of the nerve growth factor/ brain-derived neurotrophic factor family. Nature 1990;344:339-41.
26. Johnson DR. Extra toes: a new mutant gene causing multiple abnormalities in the mouse. J Embryol Exp Morph 1967;17:543-81.
27. Jones JM, Albin RL, Feldman EL, et al. mnd2: a new mouse model of inherited motor neuron disease. Genomics 1993;16:669-77.
28. Kennel PF, Finiels F, Revah F, Mallet J. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. Neuroreport 1996;7:1427-31.
29. Kennel PF, Fonteneau P, Martin E, et al. Electromyographical and motor performance studies in the pmn mouse model of neurodegenerative disease. Neurobiol Dis 1996;3:137-47.
30. Klein R, Silos-Santiago I, Smeyne RJ, et al. Disruption of the neurotrophin-3 receptor trkC eliminates Ia muscle afferents and results in abnormal movements. Nature 1994;368:249-51.
31. Koliatsos VE, Clatterbuck RE, Winslow JW, Cayouette MH, Price DL. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 1993;10:359-67.
32. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS. Neurotrophic factors: from molecule to man. Trends Neurosci 1994;17:182-90.
33. Lisovoski F, Cadusseau J, Akli S, et al. In vivo transfer of a marker gene to study motoneuronal development. Neuroreport 1994;5:1069-72.
34. Lohof AM, Ip NY, Poo MM. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 1993;363:350-3.
35. Maisonpierre PC, Belluscio L, Squinto S, et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990;247:1446-51.
36. Miller RG, Petajan JH, Bryan WW, et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann Neurol 1996;39:256-60.
37. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 1994;265:1107-10.
38. Offenhäuser N, Böhm-Matthaei R, Tsoulfas P, Parada L, Meyer M. Developmental Regulation of Full-length trkC in the Rat Sciatic Nerve. Eur J Neurosci 1995;7:917-25.
39. Quantin B, Perricaudet L, Tajbakhsh S, Mandel JL. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 1992;89:2581-4.
40. Sagot Y, Tan SA, Baetge E, Schmalbruch H, Kato AC, Aebischer P. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur J Neurosci 1995;7:1313-22.
41. Sagot Y, Tan SA, Hammang JP, Aebischer P, Kato AC. GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J Neurosci 1996;16:2335-41.
42. Sagot Y, Vejsada R, Kato AC. Clinical and molecular aspects of motoneurone diseases: animal models, neurotrophic factors and Bcl-2 oncoprotein. Trends Pharmacol Sci 1997;18:330-7.
43. Sagot Y, Rosse T, Vejsada R, Perrelet D, Kato AC. Differential effects of neurotrophic factors on motoneuron retrograde labelling in a murine model of motoneuron disease. J Neurosci 1998;18:1132-41.
44. Schmalbruch H, Jensen HS, Bjaerg M, Kamieniecka Z, Kurlan L. A new mouse mutant with progressive motor neuronopathy. J Neuropathol Exp Neurol 1991;50:192-204.
45. Sendtner M, Hotmann B, Kolbeck R, Thoenen H, Barde YA. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992;360:757-9.
46. Sendtner M, Schmalbruch H, Stockli KA, Carroll P, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 1992;358:502-4.
47. Shy ME, Tani M, Shi Y, et al. An adenoviral vector can transfer lacZ expression into Schwann cells in culture and in sciatic nerve. Ann Neurol 1995;38:429-36.
48. Sorensen J, Haase G, Krarup C, Gilgenkrantz H, Kahn A, Schmalbruch H. Gene transfer to Schwann cells after peripheral nerve injury: a new delivery system for therapeutic agents. Ann Neurol 1998;43:205-11.
49. Sterne GD, Coulton GR, Brown RA, Green CJ, Terenghi G. Neurotrophin-3-enhanced nerve regeneration selectively improves recovery of muscle fibers expressing myosin heavy chains 2b. J Cell Biol 1997;139:709-15.
50. Thoenen H. The changing scene of neurotrophic factors. Trends Neurosci 1991;14:165-70.
51. Thoenen H, Hughes RA, Sendtner M. Trophic support of motoneurons: Physiological pathophysiological, and therapeutic implications. Exp Neurol 1993;124:47-55.
52. Vejsada R, Sagot Y, Kato AC. Quantitative comparison of the transient rescue effects of neurotrophic factors on axotomized motoneurons in vivo. Eur J Neurosci 1995;7:108-15.
53. Vincent N, Ragot T, Gilgenkrantz H, et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet 1993;5:130-4.
54. Wang T, Xie KW, Lu B. Neurotrophins promote maturation of developing neuromuscular synapses. J Neurosci 1995;15:4796-805.
55. Yan Q, Elliott JL, Matheson C, et al. Influences of neurotrophins on mammalian motoneurons in vivo. J Neurobiol 1993;24:1555-77.
56. Yuen EC, Mobley WC. Therapeutic potential of neurotrophic factors for neurological disorders. Ann Neurol 1996;40:346-54.